✦ LIBER ✦

CRT-32 Universal Ticagrelor Versus Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome Patients: A Cost-Effectiveness Analysis

✍ Scribed by Limone, Brendan L.; Coleman, Craig I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of universal versus a

✍ Coleman, C.I.; Limone, B.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Ticagrelor versus Genotype-Driven Antipl

✍ Daniel J. Crespin; Jerome J. Federspiel; Andrea K. Biddle; Daniel E. Jonas; Jose 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 913 KB

Cost-Effectiveness of Universal and Plat

✍ Coleman, Craig I.; Limone, Brendan L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 336 KB

COST-EFFECTIVENESS OF GENOTYPE/PHENOTYPE

✍ Kim, Kibum; Ardati, Amer; DiDomenico, Robert; Cavallari, Larisa; Touchette, Dani 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 233 KB

COST-EFFECTIVENESS OF UNIVERSAL OR GENOT

✍ Soyon Lee; Asha Dhamija; Katelyn Parsons; Matthew King; Rajbir Kaur; Matthew Rob 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

PCV83 A Cost-Effectiveness Analysis of T

✍ P. Kritikou; J. Yfantopoulos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB